TY - JOUR
T1 - Assessment of vaccine coverage following the introduction of a publicly funded pneumococcal vaccine program for the elderly in Victoria, Australia
AU - Andrews, Ross M.
PY - 2005/4/15
Y1 - 2005/4/15
N2 - In 1998, a publicly funded pneumococcal vaccine program was introduced for persons aged ≥ 65 years in Victoria, Australia. In 2000, vaccine coverage over the previous 5 years was assessed through a telephone survey of 385 randomly selected subjects aged ≥ 65 years. Self-reported pneumococcal vaccine coverage within the previous 5 years was 46.0% (95% CI 40.5-51.6). Self-report was validated against the medical records of the nominated provider for 278 (72%) subjects. Among this subgroup, self-reported coverage was 51.1% but was 57.9% according to medical records (positive predictive value 91.5%, negative predictive value 77.2%, sensitivity 80.7%, specificity 89.7%). After accounting for response bias among those subjects for whom self-report was not validated, the revised estimate of pneumococcal vaccine coverage within the previous 5 years was 50.5% (95% CI 44.8-56.1). Comparison of vaccine coverage over time suggests the introduction of the publicly funded program in Victoria has dramatically increased coverage among the elderly.
AB - In 1998, a publicly funded pneumococcal vaccine program was introduced for persons aged ≥ 65 years in Victoria, Australia. In 2000, vaccine coverage over the previous 5 years was assessed through a telephone survey of 385 randomly selected subjects aged ≥ 65 years. Self-reported pneumococcal vaccine coverage within the previous 5 years was 46.0% (95% CI 40.5-51.6). Self-report was validated against the medical records of the nominated provider for 278 (72%) subjects. Among this subgroup, self-reported coverage was 51.1% but was 57.9% according to medical records (positive predictive value 91.5%, negative predictive value 77.2%, sensitivity 80.7%, specificity 89.7%). After accounting for response bias among those subjects for whom self-report was not validated, the revised estimate of pneumococcal vaccine coverage within the previous 5 years was 50.5% (95% CI 44.8-56.1). Comparison of vaccine coverage over time suggests the introduction of the publicly funded program in Victoria has dramatically increased coverage among the elderly.
KW - Elderly
KW - Pneumococcal polysaccharide vaccine coverage
KW - Validity
UR - http://www.scopus.com/inward/record.url?scp=15044352616&partnerID=8YFLogxK
U2 - 10.1016/j.vaccine.2004.11.039
DO - 10.1016/j.vaccine.2004.11.039
M3 - Article
SN - 0264-410X
VL - 23
SP - 2756
EP - 2761
JO - Vaccine
JF - Vaccine
IS - 21
ER -